Literature DB >> 150200

A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical study.

K Aoki.   

Abstract

Endotoxin (lipopolysaccharide, LPS) and LPS antibody in the blood were studied in 61 cases of ulcerative colitis (U.C.) by radioimmunoassay. Lysozyme (LZM) concentration was also studied by the turbidimetric method. As a result, it was found that the blood LPS value as well as serum LZM concentration reflects the clinical observations. The case of endotoxemia in the active phase group showed a positive correlation between the LPS value and LZM concentration. LPS antibody which could not be detected in many cases of the active phase, had a high titer in cases of remission with a long history of the disease. These results would suggest that in U.C. with damaged intestinal mucosal barrier, LPS originating from intestinal flora enters into the blood and aggravates the disease and further that this invading LPS releases LZM into the blood. The same studies were performed on 7 cases of Crohn's disease and the same result was obtained.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 150200

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  10 in total

Review 1.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

Authors:  Wei Jiang; Michael M Lederman; Peter Hunt; Scott F Sieg; Kathryn Haley; Benigno Rodriguez; Alan Landay; Jeffrey Martin; Elizabeth Sinclair; Ava I Asher; Steven G Deeks; Daniel C Douek; Jason M Brenchley
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

3.  Adsorbents as antiendotoxin agents in experimental colitis.

Authors:  K R Gardiner; N H Anderson; M D McCaigue; P J Erwin; M I Halliday; B J Rowlands
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

4.  Significance of systemic endotoxaemia in inflammatory bowel disease.

Authors:  K R Gardiner; M I Halliday; G R Barclay; L Milne; D Brown; S Stephens; R J Maxwell; B J Rowlands
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

5.  Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid.

Authors:  W Wellmann; P C Fink; F Benner; F W Schmidt
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

6.  Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery.

Authors:  K R Palmer; B I Duerden; C D Holdsworth
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

7.  Colitis and colonic mucosal barrier dysfunction.

Authors:  K R Gardiner; N H Anderson; B J Rowlands; A Barbul
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

8.  Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1beta.

Authors:  Ludmiła Weglarz; Joanna Wawszczyk; Arkadiusz Orchel; Marzena Jaworska-Kik; Zofia Dzierzewicz
Journal:  Dig Dis Sci       Date:  2006-12-12       Impact factor: 3.487

9.  Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.

Authors:  Monica Froicu; Margherita T Cantorna
Journal:  BMC Immunol       Date:  2007-03-30       Impact factor: 3.615

10.  Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease.

Authors:  Daniéla Oliveira Magro; Paulo Gustavo Kotze; Carlos Augusto Real Martinez; Michel Gardere Camargo; Dioze Guadagnini; Antonio Ramos Calixto; Ana Carolina Junqueira Vasques; Maria de Lourdes Setsuko Ayrizono; Bruno Geloneze; José Carlos Pareja; Mario José Saad; Claudio Saddy Rodrigues Coy
Journal:  Intest Res       Date:  2017-06-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.